Le Lézard
Classified in: Health
Subjects: NPT, LEG, AVO, FVT

End-of-Life Care Group Reaches Key Benchmarks in Helping Health Care Providers, Communities Statewide Prepare for Medical Aid-in-Dying Law


HONOLULU, Oct. 18, 2018 /PRNewswire/ -- Compassion & Choices Hawai'i today announced that its public education campaign about the Our Care, Our Choice Act has met several key benchmarks in preparation for the law to take effect on January 1, 2019.

Kat West, national director of policy and programs at Compassion & Choices

Signed into law on April 5 by Governor David Ige, the Our Care, Our Choice Act authorizes medical aid in dying as an end-of-life care option to end unbearable suffering. It is the medical practice which gives terminally ill adults with a prognosis of six months or fewer to live, and who are mentally capable of making their own healthcare decisions, the option of requesting from their doctor a prescription for medication to die peacefully in their sleep.

Compassion & Choices' Hawai'i Access Campaign is a volunteer-led effort to educate the community, healthcare professionals, health systems and hospices to ensure terminally ill adults in Hawai'i have access to the new law. To date:

Compassion & Choices has over 20 years of experience helping states successfully implement medical aid-in-dying laws.

"We know from experience that when this law goes into effect on January 1st?10 weeks from now?there will be dying patients making requests of their doctors for this compassionate end-of-life care option so medical providers need to be ready," said Kat West, national director of policy and programs. "That's why Compassion & Choices has begun reaching out to healthcare systems, hospices, physicians and pharmacists to help them prepare."

Compassion & Choices' Hawai'i Access Campaign will continue to:

  1. support local public outreach & education teams on each island;
  2. provide free education and materials for doctors, pharmacists, nurses and other healthcare providers including webinars, videos and Doc2Doc consultation calls;
  3. provide technical and policy assistance to hospitals, clinics, hospice facilities and pharmacies statewide; and
  4. work with government agencies, medical associations, and other ancillary organizations to ensure broad understanding of the law and meaningful access for those who need it.

Educational resources for patients and providers can be found at CompassionAndChoices.org/Hawaii.

As always, open and proactive patient-provider discussion about all end-of-life care options is key to smooth and successful preparation to improve end-of-life care and implement the law in a timely fashion.

"We encourage residents, no matter which island they reside on, to initiate conversations with their doctors now about whether their doctor would support them if they were to become terminally ill and request medical aid in dying. We know from experience it is only way that residents can ensure that they will get the care they want at the end of life," West said. 

Compassion & Choices Hawai'i is the local affiliate of Compassion & Choices, the nation's oldest, largest and most active nonprofit organization committed to improving care and expanding choice at the end of life. For more information call 808-282-8247 or visit www.compassionandchoices.org/Hawaii.

MEDIA CONTACT:
Aubrey Hawk, (808) 351-5800
[email protected]

 

Compassion & Choices Hawai'i logo

SOURCE Compassion & Choices


These press releases may also interest you

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

at 09:00
Arbele, a clinical-stage biotechnology company focused...

at 08:53
Alera Health, a leader in population health management integrating behavioral healthcare, is proud to announce its recognition as one of the Great Employers to Work for in North Carolina by Best Companies Group. The 2024 Great Employers to Work for...



News published on and distributed by: